Background Neurofibromatosis type 1 (NF1) is a multi‐organ disease caused by mutations in neurofibromin 1 (NF1). Amongst other features, NF1 patients frequently show reduced muscle mass and strength, impairing patients' mobility and increasing the risk of fall. The role of Nf1 in muscle and the cause for the NF1‐associated myopathy are mostly unknown. Methods To dissect the function of Nf1 in muscle, we created muscle‐specific knockout mouse models for NF1, inactivating Nf1 in the prenatal myogenic lineage either under the Lbx1 promoter or under the Myf5 promoter. Mice were analysed during prenatal and postnatal myogenesis and muscle growth. Results Nf1Lbx1 and Nf1Myf5 animals showed only mild defects in prenatal myogenesis. Nf1Lbx1 animals...
Brain-derived neurotrophic factor (BDNF) influences the differentiation, plasticity, and survival of...
AbstractPW1 is a mediator of p53 and TNFα signaling pathways previously identified in a screen to is...
AbstractSignal transduction pathways involving calcineurin and its downstream effector NFAT have bee...
Background Neurofibromatosis type 1 (NF1) is a multi-organ disease caused by mutations in neurofib...
There is emerging evidence for reduced muscle function in children with neurofibromatosis type 1 (NF...
The genetic disease neurofibromatosis type 1 (NF1) is classically associated with central nervous sy...
g.oxfordjournals.org/ D ow nloaded from 2 There is emerging evidence for reduced muscle function in ...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromin, the protein product of the neurofibromatiosis type 1 (NF1) gene, has two alternate ...
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects a range of tissue systems, however...
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects a range of tissue systems, however...
Neurofibromatosis Type 1 (NF1) is a genetic neurocutaneous disorder with multisystem manifestations,...
Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder primarily characterized by the format...
Brain-derived neurotrophic factor (BDNF) influences the differentiation, plasticity, and survival of...
AbstractPW1 is a mediator of p53 and TNFα signaling pathways previously identified in a screen to is...
AbstractSignal transduction pathways involving calcineurin and its downstream effector NFAT have bee...
Background Neurofibromatosis type 1 (NF1) is a multi-organ disease caused by mutations in neurofib...
There is emerging evidence for reduced muscle function in children with neurofibromatosis type 1 (NF...
The genetic disease neurofibromatosis type 1 (NF1) is classically associated with central nervous sy...
g.oxfordjournals.org/ D ow nloaded from 2 There is emerging evidence for reduced muscle function in ...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encodin...
Neurofibromin, the protein product of the neurofibromatiosis type 1 (NF1) gene, has two alternate ...
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects a range of tissue systems, however...
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects a range of tissue systems, however...
Neurofibromatosis Type 1 (NF1) is a genetic neurocutaneous disorder with multisystem manifestations,...
Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder primarily characterized by the format...
Brain-derived neurotrophic factor (BDNF) influences the differentiation, plasticity, and survival of...
AbstractPW1 is a mediator of p53 and TNFα signaling pathways previously identified in a screen to is...
AbstractSignal transduction pathways involving calcineurin and its downstream effector NFAT have bee...